Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma.

Autor: Reid EG; University of California, San Diego Moores Cancer Center, La Jolla, California., Shimabukuro K; Kaiser Permanente, Honolulu, Hawaii., Moore P; Corrona LLC, Waltham, Massachusetts., Ambinder RF; Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, Maryland., Bui JD; University of California, San Diego, La Jolla, California., Han S; University of Southern California, Los Angeles, California., Martínez-Maza O; UCLA AIDS Institute and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California., Dittmer DP; Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Aboulafia D; Floyd and Delores Jones Cancer Institute at Virginia Mason Medical Center, Seattle, Washington., Chiao EY; Baylor College of Medicine, Houston, Texas., Maurer T; University of California San Francisco, San Francisco, California., Baiocchi R; James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio., Mitsuyasu R; University of California, Los Angeles, Center for AIDS Research and Education, Los Angeles, California., Wachsman W; University of California, San Diego Moores Cancer Center, La Jolla, California.; Research Service, Veterans Affairs San Diego Healthcare System, San Diego, California.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jun 13; Vol. 28 (12), pp. 2646-2656.

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial.

Autor: Shindiapina P; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States., Pietrzak M; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States., Seweryn M; Biobank Lab, Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Łódź, Łódź, Poland., McLaughlin E; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States., Zhang X; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States., Makowski M; Emmes Company, Rockville, MD, United States., Ahmed EH; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States.; Department of Veterenary Biosciences, College of Veterenary Medicine, The Ohio State University, Columbus, OH, United States., Schlotter S; College of Medicine, The Ohio State University, Columbus, OH, United States., Pearson R; Department of Pathology, The Ohio State University, Columbus, OH, United States., Kitzler R; Department of Pathology, The Ohio State University, Columbus, OH, United States., Mozhenkova A; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States., Le-Rademacher J; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States., Little RF; National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Akpek G; Pacific Central Coast Health Centers, San Luis Obispo, CA, United States., Ayala E; Department of Internal Medicine, Hematology & Oncology, Mayo Clinic, Jacksonville, FL, United States., Devine SM; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN, United States., Kaplan LD; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States., Noy A; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, United States., Popat UR; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Hsu JW; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, United States., Morris LE; Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA, United States., Mendizabal AM; Emmes Company, Rockville, MD, United States., Krishnan A; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Wachsman W; Moores University of California San Diego Cancer Center, La Jolla, CA, United States.; Veterans Affairs San Diego Healthcare System, San Diego, CA, United States., Williams N; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States., Sharma N; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States., Hofmeister CC; Winship Cancer Institute, Emory University, Atlanta, GA, United States., Forman SJ; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Navarro WH; Division of Hematology/Oncology/Transplantation, University of Minnesota, Minneapolis, MN, United States.; Global Research and Development, Atara Biotherapeutics, Inc., San Francisco, CA, United States., Alvarnas JC; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Ambinder RF; Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center (SKCCC), Johns Hopkins Medical Institutions, Baltimore, MD, United States., Lozanski G; Department of Pathology, The Ohio State University, Columbus, OH, United States., Baiocchi RA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Sep 03; Vol. 12, pp. 700045. Date of Electronic Publication: 2021 Sep 03 (Print Publication: 2021).

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma.

Autor: Sparano JA; Montefiore-Einstein Cancer Center, Montefiore Medical Center, Bronx, NY, USA., Lee JY; University of Arkansas for Medical Sciences, Little Rock, AR, USA., Kaplan LD; University of California, San Francisco, San Francisco, CA, USA., Ramos JC; University of Miami, Sylvester Comprehensive Cancer Center, Miami, USA., Ambinder RF; Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD, USA., Wachsman W; Moores University of California, San Diego Cancer Center, La Jolla, CA, USA., Aboulafia D; Virginia Mason Cancer Institute, Seattle, WA, USA., Noy A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., Henry DH; University of Pennsylvania, Pennsylvania Hospital, Philadelphia, PA, USA., Ratner L; Washington University, St. Louis, MO, USA., Cesarman E; Weill Medical College of Cornell University, New York, NY, USA., Chadburn A; Weill Cornell Medical College, New York, NY, USA., Mitsuyasu R; University of California, Los Angeles Medical Center, Los Angeles, CA, USA.

Publikováno v: Haematologica [Haematologica] 2021 Mar 01; Vol. 106 (3), pp. 730-735. Date of Electronic Publication: 2021 Mar 01.

Utility and Micro-Costing Framework for TERT Promoter Mutation Analysis in Melanocytic Lesions of Uncertain Malignant Potential: A Retrospective Study in Dutch Local Clinical Practice.

Autor: Barrutia, Leire^1,2 (AUTHOR), Schuuring, Ed¹ (AUTHOR), Rácz, Emõke³ (AUTHOR), Diercks, Gilles F. H.¹ (AUTHOR), van Kempen, Léon C.^1,4 (AUTHOR) l.van.kempen@umcg.nl

Publikováno v: Diagnostics (2075-4418). Aug2024, Vol. 14 Issue 15, p1665. 13p.